With support from the Egypt Cancer Network 57357 USA, Hospital 57357 in Egypt has received the latest version of the Atellica Solution and Decapper for chemical and immunological analyses.

In a continuous effort to modernize laboratories and meet international standards, this latest addition automates sample handling, reducing errors and expediting results with utmost precision. Dr. Sonia Suleiman, Director of Laboratories, highlights its benefits in enhancing the quality of tests and ultimately improving patient care.

Moreover, the device’s scalability allows for increased testing capacity without the need for additional systems, thereby optimizing costs. Engineer Doaa Yahya emphasizes its cutting-edge technology, sourced from Siemens Healthineers, ensuring uninterrupted service and operational continuity.

This donation marks a significant step forward in advancing pediatric cancer care, demonstrating a commitment to innovation and excellence in healthcare delivery.